Also trades as: BIOV.CN (CNQ) · $vol 0M
BVAXF OTC
BioVaxys Technology Corp.
1W: -5.5%
1M: +21.9%
3M: -43.3%
YTD: -50.4%
1Y: -61.2%
3Y: -42.8%
5Y: -97.5%
$0.09
+0.00 (+0.95%)
Weekly Expected Move ±49.2%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
-76.5% ▼
Capital Expenditures
$1M
+0.0% ▲
Free Cash Flow
-$3M
-176.7% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$211K
+249.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$6M | -$12M | -$8M | -$4M |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $348K | $1M | $500K | $151K | $302K |
| Change in Working Capital | -$449K | -$83K | $2M | $2M | $54K |
| Other Non-Cash Items | -$23K | $110K | $8M | $4M | $2M |
| Operating Cash Flow | -$1M | -$5M | -$2M | -$1M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | -$1M |
| Acquisitions (Net) | $41 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $61K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $61K | $0 | $0 | $0 | -$1M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$370K | $0 | $0 | -$33K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $382K | $748K | $0 | $0 | $0 |
| Financing Cash Flow | $3M | $3M | $1M | $917K | $3M |
| Net Change in Cash | $2M | -$2M | -$451K | -$141K | $211K |
| Cash End of Period | $2M | $593K | $142K | $977 | $212K |
| Free Cash Flow | -$1M | -$5M | -$2M | -$1M | -$3M |